Irinotecan dysarthria

Author: pkbe

August undefined, 2024

WebJan 18, 2012 · Irinotecan is a prodrug that requires in vivo activation by carboxylesterases to yield its active and potent metabolite, SN-38, which works in a cell cycle phase-specific (S phase) mechanism to... WebJul 8, 2009 · The most frequent side effects of irinotecan include acute cholinergic syndrome (ACS), delayed-onset diarrhoea, and bone-marrow suppression [1]. Much more unusual is the occurrence of irinotecan-induced central nervous system (CNS) toxicity with dysarthria as the predominant symptom.

Irinotecan-Induced Dysarthria JNCI: Journal of the National …

WebMar 21, 2024 · Irinotecan (Camptosar ©, CPT-11), a topoisomerase I inhibitor, is a commonly used cytotoxic chemotherapeutic in the treatment of multiple malignancies, … WebIrinotecan-associated dysarthria: A single institution case series with management implications in patients with gastrointestinal malignancies Article Mar 2024 David Bing Zhen Rachel L McDevitt... green fern clipart

Common and Rare Side Effects for Irinotecan HCL Vial - WebMD

WebSep 2, 2024 · Hence irinotecan may cause overstimulation of hypoglossal nerve leading to dysarthria. Oxaliplatin is known to potentiate the cholinergic effects of irinotecan by … Irinotecan-based chemotherapy regimens are used worldwide in the treatment of recurrent or advanced gastrointestinal (GI) cancers, in combination with other cytotoxic drugs or monoclonal antibodies. The most common side effects include acute cholinergic syndrome (ACS) mediated through the inhibition … See more A 49-year-old man diagnosed with locally advanced rectal cancer at the end of 2006 was treated with neoadjuvant radiotherapy combined with capecitabine followed by surgery in February 2007. From April to July 2007 he received … See more A 58-year-old man was diagnosed with locally advanced pancreatic adenocarcinoma in October 2013. The patient had a good … See more A 36-year-old woman underwent right hemicolectomy due to adenocarcinoma in July 2009. The pathological stage at diagnosis was … See more In May 2012, a 60-year-old man underwent right hemicolectomy for adenocarcinoma of the right colon. The pathology report showed poorly differentiated adenocarcinoma of the ileocecal valve (stage pT3 N2 M0) … See more Webdysarthria while receiving intravenous infusion of irinotecan. In all our cases, dysarthria occurred during the infusion of the ﬁrst course of irinotecan, and then resolved rapidly without any sequelae. Imaging of the brain was per-formed, but failed to show any evidence of an acute neurological event. We also reviewed the greenfern industries shares

Irinotecan-Induced Transient Dysarthria: Case Series and …

Irinotecan: Package Insert - Drugs.com

WebNational Center for Biotechnology Information WebJul 1, 2008 · Europe PMC is an archive of life sciences journal literature. greenfern investmentWebBACKGROUND: Irinotecan, a topoisomerase I inhibitor, is a cytotoxic chemotherapeutic agent used to treat multiple malignancies, including those of colorectal, pancreatic, cervical, esophageal, gastric, and lung origin.Dysarthria, a state of difficult or unclear articulation of speech, has been reported as a rare side effect of irinotecan through multiple case … fluke technologies private limited

"WebJul 26, 2024 · The patient was able to tolerate this reaction and received 20 cycles of irinotecan-based chemotherapy despite experiencing the muscle twitching with every cycle at the same onset, duration, and severity. It is possible that competitive metabolism by concomitant medications metabolized by CYP3A4 or UGT1A1 was responsible for this … " - Irinotecan dysarthria

Irinotecan dysarthria

Irinotecan-associated dysarthria in patients with pancreatic …

WebJul 1, 2013 · Summary A 49-year-old man with meta-static colon cancer undergoing treatment with i.v. irinotecan (180 mg/m 2 to be infused over 120 minutes) as part of a … WebJul 23, 2024 · Irinotecan is a topoisomerase-I inhibitor that is commonly used in combination with other chemotherapy agents for gastrointestinal malignancies. It has …

Did you know?

WebApr 1, 2024 · Irinotecan-induced dysarthria has been reported in the literature, but the underlying mechanism of this neurotoxicity remains unclear. Here, we present a 35-year-old female with metastatic colon cancer who experienced dysarthria during irinotecan infusion. WebJan 18, 2012 · Irinotecan is a prodrug that requires in vivo activation by carboxylesterases to yield its active and potent metabolite, SN-38, which works in a cell cycle phase-specific (S …

WebJun 28, 2024 · Dysarthria, a state of difficult or unclear articulation of speech, has been reported as a rare side effect of irinotecan through multiple case reports and case … WebJul 1, 2008 · DISCUSSION. The mechanism by which irinotecan and its active metabolite SN-38 binds and inhibits anticholinesterase has been well described; 4, 5 however, the mechanism by which CNS toxicity occurs after irinotecan infusion is unclear. We are aware of four cases of irinotecaninduced dysarthria reported in the literature, 9 – 12 but to the …

WebSep 12, 2024 · Hence irinotecan may cause overstimulation of hypoglossal nerve leading to dysarthria. Oxaliplatin is known to potentiate the cholinergic effects of irinotecan by causing neuronal... WebNational Center for Biotechnology Information

WebJan 19, 2013 · Irinotecan. A 34-year-old man with metastatic sarcoma and a 63-year-old woman with disseminated adenocarcinoma developed CNS toxicity with dysarthria during treatment with irinotecan. The woman also experienced an acute cholinergic syndrome. The man, who had experienced partial remission of his sarcoma following antineoplastic …

WebSep 19, 2001 · Irinotecan (CPT-11) is a semisynthetic analogue of camptothecin with antitumor activity in solid neoplasias. Camptothecin inhibits topoisomerase I and impedes the uncoiling of the DNA double helix, thus delaying its replication and cell division. Currently, CPT-11 combined with 5-fluorouracil (5-FU) is used as a first-line treatment of advanced ... fluke t90 voltage \\u0026 continuity tester yellowWebAug 11, 2015 · In all cases, dysarthria occurred during the infusion of irinotecan in the first course of treatment, persisted for several hours, and then resolved rapidly without any sequelae. Physical and neurological examinations at the onset of dysarthria revealed no other abnormalities. Imaging studies revealed no abnormal findings. fluke t6-1000 electrical testerWebThe topoisomerase I inhibitor irinotecan is a widely used cytotoxic drug [1]. The most frequent side effects of irinotecan include acute cholinergic syn-drome (ACS), delayed-onset diarrhoea, and bone-marrow suppression [1]. Much more unusual is the occurrence of irinotecan-induced central nervous system (CNS) toxicity with dysarthria as the pre- fluke technical support phone number fluke t6-600 replacement test leadsWebby Irinotecan in the form of dysarthria is an uncommon adverse event in which the pathologic mechanism has not been fully elucidated. Dysarthria is a motor speech disorder characterized by problems with articulation, phonetics and prosody. It can be caused by central or peripheral nervous system damage leading to the loss of control of the green fern leaf print hoodieWebJun 28, 2024 · Dysarthria, a state of difficult or unclear articulation of speech, has been reported as a rare side effect of irinotecan through multiple case reports and case series, … fluke tachometer non contactWebAbstract. Irinotecan (Camptosar ©, CPT-11), a topoisomerase I inhibitor, is a commonly used cytotoxic chemotherapeutic in the treatment of multiple malignancies, particularly … green fern garden furniture reviews